News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,233 Results
Type
Article (13875)
Company Profile (101)
Press Release (253257)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88199)
Career Advice (465)
Deals (15364)
Drug Delivery (67)
Drug Development (36622)
Employer Resources (49)
FDA (6320)
Job Trends (6220)
News (150517)
Policy (14193)
Tag
Academia (445)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (23262)
ALS (39)
Alzheimer's disease (396)
Antibody-drug conjugate (ADC) (46)
Approvals (6365)
Artificial intelligence (115)
Autoimmune disease (9)
Automation (5)
Bankruptcy (149)
Best Places to Work (4385)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (84)
Cancer (670)
Cardiovascular disease (74)
Career advice (409)
Career pathing (12)
CAR-T (24)
Cell therapy (94)
Cervical cancer (5)
Clinical research (31013)
Collaboration (372)
Compensation (168)
Complete response letters (17)
COVID-19 (761)
CRISPR (23)
C-suite (135)
Cystic fibrosis (39)
Data (732)
Denatured (15)
Depression (10)
Diabetes (84)
Diagnostics (1341)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (62)
Drug pricing (71)
Drug shortages (12)
Duchenne muscular dystrophy (41)
Earnings (32519)
Editorial (14)
Employer branding (4)
Employer resources (43)
Events (37754)
Executive appointments (414)
FDA (6832)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (228)
Gene editing (41)
Generative AI (9)
Gene therapy (106)
GLP-1 (355)
Government (1365)
Grass and pollen (3)
Guidances (75)
Healthcare (3663)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (39)
Indications (14)
Infectious disease (796)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (50)
Interviews (59)
IPO (5906)
IRA (29)
Job creations (2054)
Job search strategy (373)
Kidney cancer (6)
Labor market (14)
Layoffs (184)
Leadership (4)
Legal (3451)
Liver cancer (19)
Lung cancer (88)
Lymphoma (63)
Machine learning (4)
Management (16)
Manufacturing (177)
MASH (37)
Medical device (1318)
Medtech (1320)
Mergers & acquisitions (9682)
Metabolic disorders (275)
Multiple sclerosis (23)
NASH (14)
Neurodegenerative disease (29)
Neuropsychiatric disorders (9)
Neuroscience (596)
NextGen: Class of 2025 (1593)
Non-profit (675)
Now hiring (8)
Obesity (155)
Opinion (119)
Ovarian cancer (22)
Pain (58)
Pancreatic cancer (17)
Parkinson's disease (48)
Partnered (7)
Patents (131)
Patient recruitment (30)
Peanut (10)
People (29055)
Pharmaceutical (64)
Pharmacy benefit managers (13)
Phase I (8075)
Phase II (13116)
Phase III (11776)
Pipeline (581)
Policy (75)
Postmarket research (1401)
Preclinical (3241)
Press Release (25)
Prostate cancer (49)
Psychedelics (8)
Radiopharmaceuticals (121)
Rare diseases (178)
Real estate (2642)
Recruiting (17)
Regulatory (10255)
Reports (14)
Research institute (573)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (3)
RSV (8)
Schizophrenia (39)
Series A (40)
Series B (16)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1630)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (39)
The Weekly (30)
Vaccines (162)
Venture capitalists (14)
Weight loss (101)
Women's health (8)
Worklife (4)
Date
Today (80)
Last 7 days (325)
Last 30 days (1198)
Last 365 days (11725)
2025 (4516)
2024 (12568)
2023 (14271)
2022 (19582)
2021 (20094)
2020 (19079)
2019 (15008)
2018 (11821)
2017 (13902)
2016 (13146)
2015 (15492)
2014 (12444)
2013 (10611)
2012 (11406)
2011 (11937)
2010 (10899)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (59)
Arkansas (3)
Asia (20195)
Australia (2620)
California (1909)
Canada (972)
China (257)
Colorado (78)
Connecticut (74)
Delaware (64)
Europe (39661)
Florida (366)
Georgia (43)
Idaho (9)
Illinois (214)
India (16)
Indiana (142)
Iowa (1)
Japan (106)
Kansas (65)
Kentucky (13)
Louisiana (2)
Maine (2)
Maryland (286)
Massachusetts (1643)
Michigan (32)
Minnesota (102)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (836)
New Mexico (7)
New York (558)
North Carolina (414)
North Dakota (2)
Northern California (793)
Ohio (51)
Oklahoma (4)
Oregon (17)
Pennsylvania (480)
Puerto Rico (8)
Rhode Island (10)
South America (503)
South Carolina (3)
Southern California (804)
Tennessee (36)
Texas (256)
United States (7929)
Utah (36)
Virginia (85)
Washington D.C. (32)
Washington State (128)
Wisconsin (21)
267,233 Results for "eci pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ECI Pharmaceuticals LLC Signs Agreement to Be Exclusive U.S. Distributor of Generic Cialis®
ECI Pharmaceuticals, LLC (ECI) today announced that it has entered into an exclusive U.S. agreement with Qilu Pharmaceutical Co., Ltd. (Qilu) to manage the sales, marketing, and distribution for the therapeutically equivalent generic of Cialis®, with strengths of 2.5mg, 5mg, 10mg, and 20mg tablets.
May 10, 2021
·
1 min read
ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen Prescription Strength Tablets and Folic Acid Prescription Strength Tablets
ECI Pharmaceuticals, LLC (ECI) today announced that it has entered into an exclusive U.S. distribution agreement with AiPing Pharmaceuticals, Inc. (AiPing) to manage the sales, marketing, and distribution of Ibuprofen 400 mg, 600 mg, 800 mg tablets, and Folic Acid 1 mg tablets.
April 23, 2021
·
2 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Apellis Pharmaceuticals to Present at Upcoming May 2025 Investor Conferences
May 7, 2025
·
1 min read
Press Releases
Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
May 14, 2025
·
8 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options
May 15, 2025
·
5 min read
Press Releases
X4 Pharmaceuticals Announces Reverse Stock Split
April 24, 2025
·
6 min read
Press Releases
Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results
May 7, 2025
·
19 min read
Press Releases
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
May 7, 2025
·
3 min read
1 of 26,724
Next
